Clinical features of the 62 patients with EATL
| Feature . | . |
|---|---|
| Age, y | |
| Median | 60 (61) |
| Range | 33-81 (61) |
| Sex | |
| Male | 53% (33) |
| Female | 47% (29) |
| Stage | |
| IE | 10% (6) |
| IIE | 21% (13) |
| IIIE | 5% (3) |
| IV | 64% (39) |
| B symptoms | |
| No | 37% (23) |
| Yes | 63% (39) |
| Largest mass | |
| < 5 cm | 37% (17) |
| ≥ 5 cm | 63% (29) |
| Bone marrow involvement | |
| No | 97% (60) |
| Yes | 3% (2) |
| Elevated LDH | |
| No | 65% (37) |
| Yes | 35% (20) |
| Hypercalcemia | |
| No | 91% (46) |
| Yes | 9% (3) |
| Elevated CRP | |
| No | 17% (9) |
| Yes | 33% (25) |
| History of celiac sprue | |
| No | 52% (32) |
| Yes | 32% (20) |
| Symptoms | |
| Abdominal pain | 88% (30) |
| Fatigue | 38% (13) |
| Anorexia | 38% (13) |
| Infection | 23% (8) |
| Adenopathy | 15% (5) |
| Hepatomegaly | 6% (2) |
| Splenomegaly | 6% (2) |
| Pruritus | 3% (1) |
| IPI score | |
| 0/1 | 25% (14) |
| 2 | 30% (17) |
| 3 | 32% (18) |
| 4/5 | 12% (7) |
| PIT score | |
| 0 | 25% (14) |
| 1 | 34% (19) |
| 2 | 32% (18) |
| 3-4 | 9% (5) |
| 5-yr OS | 20% (61) |
| 5-yr FFS | 4% (61) |
| Feature . | . |
|---|---|
| Age, y | |
| Median | 60 (61) |
| Range | 33-81 (61) |
| Sex | |
| Male | 53% (33) |
| Female | 47% (29) |
| Stage | |
| IE | 10% (6) |
| IIE | 21% (13) |
| IIIE | 5% (3) |
| IV | 64% (39) |
| B symptoms | |
| No | 37% (23) |
| Yes | 63% (39) |
| Largest mass | |
| < 5 cm | 37% (17) |
| ≥ 5 cm | 63% (29) |
| Bone marrow involvement | |
| No | 97% (60) |
| Yes | 3% (2) |
| Elevated LDH | |
| No | 65% (37) |
| Yes | 35% (20) |
| Hypercalcemia | |
| No | 91% (46) |
| Yes | 9% (3) |
| Elevated CRP | |
| No | 17% (9) |
| Yes | 33% (25) |
| History of celiac sprue | |
| No | 52% (32) |
| Yes | 32% (20) |
| Symptoms | |
| Abdominal pain | 88% (30) |
| Fatigue | 38% (13) |
| Anorexia | 38% (13) |
| Infection | 23% (8) |
| Adenopathy | 15% (5) |
| Hepatomegaly | 6% (2) |
| Splenomegaly | 6% (2) |
| Pruritus | 3% (1) |
| IPI score | |
| 0/1 | 25% (14) |
| 2 | 30% (17) |
| 3 | 32% (18) |
| 4/5 | 12% (7) |
| PIT score | |
| 0 | 25% (14) |
| 1 | 34% (19) |
| 2 | 32% (18) |
| 3-4 | 9% (5) |
| 5-yr OS | 20% (61) |
| 5-yr FFS | 4% (61) |
The numbers in parentheses represent the number of patients with the respective feature or the number of patients analyzed for this parameter.